EGFR and non-small cell lung carcinoma: In EGFR-mutated NSCLC cells, activated EGFR was found to elevate PD-L1 expression via the IL-6/JAK/STAT3 signaling or p-ERK1/2/p-c-Jun pathway (35, 36).